Both Th17 and Tregs were enriched in tumors or marginal region of HCC and increased intratumoral IL-17-producing cell or Tregs density predicted poor prognosis in HCC patients [19–21]. The gene discussed is IL17A; the disease is hepatocellular carcinoma.